Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $590.64 million. The enterprise value is $1.12 billion.

Market Cap	590.64M
Enterprise Value	1.12B

Important Dates

The next confirmed earnings date is Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ESPR has 231.62 million shares outstanding. The number of shares has increased by 18.70% in one year.

Current Share Class	231.62M
Shares Outstanding	231.62M
Shares Change (YoY)	+18.70%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	44.84%
Float	230.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	13.01
PS Ratio	1.91
Forward PS	1.47
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.37

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-10.37%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$999,349
Profits Per Employee	-$348,128
Employee Count	304
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.52% in the last 52 weeks. The beta is 1.04, so ESPR's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+20.52%
50-Day Moving Average	2.70
200-Day Moving Average	1.72
Relative Strength Index (RSI)	43.37
Average Volume (20 Days)	5,570,322

Short Selling Information

The latest short interest is 24.42 million, so 10.54% of the outstanding shares have been sold short.

Short Interest	24.42M
Short Previous Month	27.69M
Short % of Shares Out	10.54%
Short % of Float	10.62%
Short Ratio (days to cover)	2.90

Income Statement

In the last 12 months, ESPR had revenue of $303.80 million and -$105.83 million in losses. Loss per share was -$0.54.

Revenue	303.80M
Gross Profit	130.56M
Operating Income	-29.38M
Pretax Income	-105.83M
Net Income	-105.83M
EBITDA	-29.27M
EBIT	-29.38M
Loss Per Share	-$0.54

Balance Sheet

The company has $86.06 million in cash and $598.18 million in debt, giving a net cash position of -$512.12 million or -$2.21 per share.

Cash & Cash Equivalents	86.06M
Total Debt	598.18M
Net Cash	-512.12M
Net Cash Per Share	-$2.21
Equity (Book Value)	-433.51M
Book Value Per Share	-2.17
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 42.98%, with operating and profit margins of -9.67% and -34.84%.

Gross Margin	42.98%
Operating Margin	-9.67%
Pretax Margin	-34.84%
Profit Margin	-34.84%
EBITDA Margin	-9.64%
EBIT Margin	-9.67%
FCF Margin	n/a

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.70%
Shareholder Yield	-18.70%
Earnings Yield	-17.51%
FCF Yield	n/a

Analyst Forecast

The average price target for ESPR is $6.50, which is 154.90% higher than the current price. The consensus rating is "Buy".

Price Target	$6.50
Price Target Difference	154.90%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	29.02%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a